Serum metabolic profiles in overweight and obese women with and without metabolic syndrome

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Cheng, Sulin ^a   Wiklund, Petri K ^a,b   Pekkala, Satu ^a   Autio, Reija ^c   Munukka, Eveliina ^a   Xu, Leiting ^d   Saltevo, Juha ^e   Cheng, Shumei ^a   Kujala, Urho M ^a   Alen, Markku ^b,f  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NINGBO UNIVERSITY   (China)

^e Central Finland Central Hospital   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Metabolic syndrome; Metabolomics; Obesity; Women

Indexed keywords

AROMATIC AMINO ACID; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; FATTY ACID; GLUCOSE; GLYCEROPHOSPHOLIPID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 7 FATTY ACID; OMEGA 9 FATTY ACID; OROSOMUCOID; PHENYLALANINE; PHOSPHORYLCHOLINE; TRIACYLGLYCEROL; TYROSINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; FAT MASS; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84898404839     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-40     Document Type: Article

References (46)

1. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, Curr Opin Cardiol 2006 21 1 1 6 10.1097/01.hco.0000200416.65370.a0 16355022 (Pubitemid 43194325)
2. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, Arch Intern Med 2003 163 4 427 436 10.1001/archinte.163.4.427 12588201 (Pubitemid 36241019)
3. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Muoio DM, Newgard CB, Nat Rev Mol Cell Biol 2008 9 3 193 205 10.1038/nrm2327 18200017 (Pubitemid 351301824)
4. Ectopic fat accumulation and metabolic syndrome. Rasouli N, Molavi B, Elbein SC, Kern PA, Diabetes Obes Metab 2007 9 1 1 10 10.1111/j.1463-1326.2006. 00590.x (Pubitemid 44921036)
5. Women with and without metabolic disorder differ in their gut microbiota composition. Munukka E, Wiklund P, Pekkala S, Volgyi E, Xu L, Cheng S, Lyytikainen A, Marjomaki V, Alen M, Vaahtovuo J, Keinänen-Kiukaanniemi S, Cheng S, Obesity (Silver Spring) 2012 20 5 1082 1087 10.1038/oby.2012.8 22293842
6. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Guilherme A, Virbasius JV, Puri V, Czech MP, Nat Rev Mol Cell Biol 2008 9 5 367 377 10.1038/nrm2391 18401346 (Pubitemid 351574198)
7. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA, Nutr Rev 2010 68 4 214 231 10.1111/j.1753-4887.2010.00280.x 20416018
8. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity. Gill JM, Malkova D, Clin Sci (Lond) 2006 110 4 409 425 10.1042/CS20050207 16526946
9. Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes. Kujala UM, Jokelainen J, Oksa H, Saaristo T, Rautio N, Moilanen L, Korpi-Hyovalti E, Saltevo J, Vanhala M, Niskanen L, Peltonen M, Tuomilehto J, Uusitupa M, Keinänen-Kiukaannemi S, BMJ Open 2011 1 2 000292 22184585
10. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D survey. Pajunen P, Kotronen A, Korpi-Hyovalti E, Keinanen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M, Uusitupa M, Peltonen M, BMC Public Health 2011 11 754 10.1186/1471-2458-11-754 21962038
11. Metabolic and body composition factors in subgroups of obesity: what do we know? Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET, J Clin Endocrinol Metab 2004 89 6 2569 2575 10.1210/jc.2004-0165 15181025 (Pubitemid 38766333)
12. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Bluher M, Curr Opin Lipidol 2010 21 1 38 43 10.1097/MOL. 0b013e3283346ccc 19915462
13. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
14. Food consumption and nutrient intakes with a special focus on milk product consumption in early pubertal girls in central Finland. Lyytikainen A, Lamberg-Allardt C, Kannas L, Cheng S, Public Health Nutr 2005 8 3 284 289 15918925 (Pubitemid 40695068)
15. Long-term leisure-time physical activity has a positive effect on bone mass gain in girls. Volgyi E, Lyytikainen A, Tylavsky FA, Nicholson PH, Suominen H, Alen M, Cheng S, J Bone Miner Res 2010 25 5 1034 1041 19929440
16. New methods for calculating metabolic rate with special reference to protein metabolism: 1949. Weir JB, Nutrition 1990 6 3 213 221 2136000
17. Metabonomic, transcriptomic, and genomic variation of a population cohort. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, Hamalainen E, Jousilahti P, Kangas AJ, Männisto S, Savolainen MJ, Jula M, Leiviskä J, Palotie A, Salomaa V, Perola M, Ala-Korpela M, Peltonen L, Mol Syst Biol 2010 6 441 21179014
18. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, Jarvelin MR, Kahonen M, Lehtimaki T, Viikari J, Raitakari OT, Savolainen MJ, Alakorpela M, Analyst 2009 134 9 1781 1785 10.1039/b910205a 19684899
19. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikainen LP, Kangas AJ, Soininen P, Wurtz P, Silander K, Dick DM, Rose RJ, Savolainen MJ, Viikari J, Kähönen M, Lehtimäki T, Pietiläinen KH, Inouye M, McCarthy MI, Jula M, Eriksson J, Raitakari OT, Salomaa V, Kaprio J, Järvelin MR, Peltonen L, Perola M, Freimer NB, Ala-korpela M, Palotie A, et al. Nat Genet 2012 44 3 269 276 10.1038/ng.1073 22286219
20. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men. Stancakova A, Paananen J, Soininen P, Kangas AJ, Bonnycastle LL, Morken MA, Collins FS, Jackson AU, Boehnke ML, Kuusisto J, Ala-korpela M, Kuusisto M, Diabetes 2011 60 5 1608 1616 10.2337/db10-1655 21421807
21. Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane study). Makinen VP, Forsblom C, Thorn LM, Waden J, Kaski K, Ala-Korpela M, Groop PH, Cardiovasc Diabetol 2009 8 54 10.1186/1475-2840-8-54 19804653
22. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P, Arterioscler Thromb Vasc Biol 2008 28 6 1039 1049 10.1161/ATVBAHA.107.159228 18356555
23. Characterizing the profile of obese patients who are metabolically healthy. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R, Int J Obes (Lond) 2011 35 7 971 981 10.1038/ijo.2010.216 20975726
24. Genetic links between diabetes mellitus and coronary atherosclerosis. Ordovas JM, Curr Atheroscler Rep 2007 9 3 204 210 10.1007/s11883-007-0020-9 18241614 (Pubitemid 47629068)
25. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Chrousos GP, Int J Obes Relat Metab Disord 2000 24 Suppl 2 50 S55 10997609
26. The metabolic syndrome and adipocytokines. Matsuzawa Y, FEBS Lett 2006 580 12 2917 2921 10.1016/j.febslet.2006.04.028 16674947 (Pubitemid 43729162)
27. Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms. Lasselin J, Capuron L, Neuroimmunomodulation 2014 21 2-3 95 101 24557041
28. Increased oxidative stress in obesity and its impact on metabolic syndrome. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I, J Clin Invest 2004 114 12 1752 1761 10.1172/JCI21625 15599400 (Pubitemid 40385531)
29. Metabolic syndrome: role of maternal undernutrition and fetal programming. Lakshmy R, Rev Endocr Metab Disord 2013 14 3 229 240 10.1007/s11154-013-9266-4 24005943
30. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, Muehlbauer M, Patel MJ, Stevens RD, Appel LJ, Newby LK, Svetkey LP, Metabolism 2013 62 7 961 969 10.1016/j.metabol.2013.01.007 23375209
31. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Lackey DE, Lynch CJ, Olson KC, Mostaedi R, Ali M, Smith WH, Karpe F, Humphreys S, Bedinger DH, Dunn TN, Thomas AP, Oort PJ, Kieffer DA, Amin R, Bettaieb A, Haj FG, Permana P, Anthony TG, Adams SH, Am J Physiol Endocrinol Metab 2013 304 11 1175 E1187 10.1152/ajpendo.00630.2012 23512805
32. Plasma amino acid levels and insulin secretion in obesity. Felig P, Marliss E, Cahill GF Jr, N Engl J Med 1969 281 15 811 816 10.1056/ NEJM196910092811503 5809519
33. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, Kraus WE, Diabetes Care 2009 32 9 1678 1683 10.2337/dc08-2075 19502541
34. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB, Diabetologia 2010 53 4 757 767 10.1007/s00125-009-1637-8 20076942
35. Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. Higuchi N, Kato M, Miyazaki M, Tanaka M, Kohjima M, Ito T, Nakamuta M, Enjoji M, Kotoh K, Takayanagi R, J Cell Biochem 2011 112 1 30 38 10.1002/jcb.22688 20506195
36. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Razavizade M, Jamali R, Arj A, Talari H, Hepatobiliary Pancreat Dis Int 2012 11 5 513 520 10.1016/S1499-3872(12)60216-1 23060397
37. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Kotronen A, Yki-Jarvinen H, Sevastianova K, Bergholm R, Hakkarainen A, Pietilainen KH, Juurinen L, Lundbom N, Sorensen TI, Obesity (Silver Spring) 2011 19 1 23 28 10.1038/oby.2010.137 20539297
38. Alpha-1-acid glycoprotein. Fournier T, Medjoubi NN, Porquet D, Biochim Biophys Acta 2000 1482 1-2 157 171 11058758
39. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. Lee YS, Choi JW, Hwang I, Lee JW, Lee JH, Kim AY, Huh JY, Koh YJ, Koh GY, Son HJ, Masuzaki H, Hotta K, Alfadda AA, Kim JB, J Biol Chem 2010 285 29 22174 22185 10.1074/jbc.M109.085464 20442402
40. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE, J Biol Chem 2005 280 6 4617 4626 15536073 (Pubitemid 40288630)
41. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3 T3-L1 adipocytes. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW, Olefsky JM, J Biol Chem 2005 280 42 35361 35371 10.1074/jbc.M504611200 16085647 (Pubitemid 41532725)
42. Long-term leisure-time physical activity and serum metabolome. Kujala UM, Makinen VP, Heinonen I, Soininen P, Kangas AJ, Leskinen TH, Rahkila P, Wurtz P, Kovanen V, Cheng S, Sipilä S, Hirvensalo M, Telama R, Tammelin T, Savolainen MJ, Pouta A, O'Reilly PF, Mäntyselkä P, Viikari J, Kähönen M, Lehtimäki T, Elliott P, Vanhala MJ, Raitakari OT, Järvelin MR, Kaprio J, Kainulainen H, Ala-Korpela M, Circulation 2013 127 3 340 348 10.1161/CIRCULATIONAHA.112.105551 23258601
43. Differences in muscle and adipose tissue gene expression and cardio-metabolic risk factors in the members of physical activity discordant twin pairs. Leskinen T, Rinnankoski-Tuikka R, Rintala M, Seppanen-Laakso T, Pollanen E, Alen M, Sipila S, Kaprio J, Kovanen V, Rahkila P, Oresic M, Kainulainen H, Kujala UM, PLoS One 2010 5 9 12609 10.1371/journal.pone.0012609 20862330
44. Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk. Kivela R, Silvennoinen M, Lehti M, Rinnankoski-Tuikka R, Purhonen T, Ketola T, Pullinen K, Vuento M, Mutanen N, Sartor MA, Reunanen H, Koch LG, Britton SL, Kainulainen H, FASEB J 2010 24 11 4565 4574 10.1096/fj.10-157313 20643908
45. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Kahn R, Buse J, Ferrannini E, Stern M, Diabetologia 2005 48 9 1684 1699 10.1007/s00125-005-1876-2 16079964 (Pubitemid 41317821)
46. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC, Diabetologia 1985 28 7 401 411 10.1007/BF00280882 3899824 (Pubitemid 15018831)